Dr. Reddy's Laboratories Limited (RDY) Income Quarterly - Discounting Cash Flows
RDY
Dr. Reddy's Laboratories Limited
RDY (NYSE)
Period Ending: LTM
(Last Twelve Months)
2026 (Q2)
09-30
2026 (Q1)
06-30
2025 (Q4)
03-31
2025 (Q3)
12-31
2025 (Q2)
09-30
2025 (Q1)
06-30
2024 (Q4)
03-31
2024 (Q3)
12-31
2024 (Q2)
09-30
2024 (Q1)
06-30
2023 (Q4)
03-31
2023 (Q3)
12-31
2023 (Q2)
09-30
2023 (Q1)
06-30
2022 (Q4)
03-31
2022 (Q3)
12-31
2022 (Q2)
09-30
2022 (Q1)
06-30
2021 (Q4)
03-31
2021 (Q3)
12-31
2021 (Q2)
09-30
2021 (Q1)
06-30
2020 (Q4)
03-31
2020 (Q3)
12-31
2020 (Q2)
09-30
2020 (Q1)
06-30
2019 (Q4)
03-31
2019 (Q3)
12-31
2019 (Q2)
09-30
2019 (Q1)
06-30
2018 (Q4)
03-31
2018 (Q3)
12-31
2018 (Q2)
09-30
2018 (Q1)
06-30
2017 (Q4)
03-31
2017 (Q3)
12-31
2017 (Q2)
09-30
2017 (Q1)
06-30
2016 (Q4)
03-31
2016 (Q3)
12-31
2016 (Q2)
09-30
2016 (Q1)
06-30
2015 (Q4)
03-31
2015 (Q3)
12-31
2015 (Q2)
09-30
2015 (Q1)
06-30
2014 (Q4)
03-31
2014 (Q3)
12-31
2014 (Q2)
09-30
2014 (Q1)
06-30
2013 (Q4)
03-31
2013 (Q3)
12-31
2013 (Q2)
09-30
2013 (Q1)
06-30
2012 (Q4)
03-31
2012 (Q3)
02-06
2012 (Q2)
09-30
2012 (Q1)
06-30
2011 (Q4)
03-31
2011 (Q3)
12-31
2011 (Q2)
09-30
2011 (Q1)
06-30
2010 (Q4)
03-31
2010 (Q3)
12-31
2010 (Q2)
09-30
2010 (Q1)
06-30
2009 (Q4)
03-31
2009 (Q3)
12-31
2009 (Q2)
09-30
2009 (Q1)
06-30
2008 (Q4)
03-31
2008 (Q3)
12-31
2008 (Q2)
09-30
2008 (Q1)
06-30
2007 (Q4)
03-31
2007 (Q3)
12-31
2007 (Q2)
09-30
2007 (Q1)
06-30
2006 (Q4)
03-31
2006 (Q3)
12-31
2006 (Q2)
09-30
2006 (Q1)
06-30
2005 (Q4)
03-31
2005 (Q3)
12-31
2005 (Q2)
09-30
2005 (Q1)
06-30
2004 (Q4)
03-31
2004 (Q3)
12-31
2004 (Q2)
09-30
2004 (Q1)
06-30
2003 (Q4)
03-31
2003 (Q3)
12-31
2003 (Q2)
09-30
2003 (Q1)
06-30
2002 (Q4)
03-31
2002 (Q3)
12-31
2002 (Q2)
09-30
2002 (Q1)
06-30
Report Filing 2025-10-24 2025-10-24 2025-06-30 2025-06-06 2024-12-31 2024-09-30 2024-06-30
1234
Revenue 342,149 88,051 85,452 85,060 83,586 80,162 76,727
1234
Cost of Revenue 149,067 39,911 36,825 37,797 34,534 32,393 30,383
1234
Gross Profit 193,082 48,140 48,627 47,263 49,052 47,769 46,344
1234
Operating Expenses 121,727 30,627 31,152 29,616 30,332 30,218 28,419
1234
Research & Development 26,362 6,202 6,244 7,258 6,658 7,271 6,193
1234
Selling, General and Administrative 97,789 26,436 23,181 24,055 24,117 23,007 22,691
1234
Other Operating Expenses -2,424 -2,011 1,727 -1,697 -443 -60 -465
1234
Operating Income 71,355 17,513 17,475 17,647 18,720 17,551 17,925
1234
Net Non-Operating Interest 866 774 298 -92 -114 -92 0
1234
Interest Income 4,077 1,681 1,128 564 704 665 0
1234
Interest Expense 3,211 907 830 656 818 757 0
1234
Equity & Other Income/(Expense) 3,972 63 1,274 2,499 136 1,708 896
1234
Income Before Tax 76,193 18,350 19,047 20,054 18,742 19,167 18,821
1234
Income Tax Expense 17,919 4,082 4,951 4,182 4,704 5,752 4,901
1234
Income Attributable to Non-Controlling Interest -347 -104 -82 -66 -95 862 0
1234
Net Income 58,621 14,372 14,178 15,938 14,133 12,553 13,920
1234
Depreciation and Amortization 19,089 5,051 4,765 4,554 4,719 3,975 3,810
1234
EBITDA 90,444 22,564 22,240 22,201 23,439 21,526 21,735
1234
Earnings Per Share (EPS) 70.4 17.27 17.04 19.13 16.96 15.06 16.69
1234
Diluted Earnings Per Share 70.31 17.25 17.02 19.1 16.94 15.05 16.69
1234
Weighted Average Shares Outstanding 832 832 832 833.3 833.3 833.6 833.9
1234
Diluted Weighted Average Shares Outstanding 833 833 833 834.3 834.3 834.1 833.9
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program